SEC Form 4 research
| Issuer | Entera Bio Ltd. |
|---|---|
| Tickers | ENTX |
| Reporting owners | 20 |
| Officers and directors | 13 |
| Last public filing | 2026-08-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-07 | 2026-08-07 | Rubin Steven D | A | 19,117 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Rubin Steven D | A | 43,405 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Rubin Steven D | A | 33,368 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Malca Yonatan | A | 22,815 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Taitel Haya | A | 20,790 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Ellis Sean | A | 20,034 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Ellis Sean | A | 40,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Yaacov-Garbeli Dana | A | 140,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Galitzer Hillel | A | 200,000 | $0 | Not reported |
| 2026-08-07 | 2026-08-07 | Burshtein Gregory | A | 180,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.